Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Squamous Cell

Explore clinical trials studying Carcinoma, Squamous Cell. Study availability and eligibility vary by location and protocol.

1,631 public trials 442 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Squamous Cell trial results

Completed

Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma

NCT04490564

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +24 more
Locations
  • University General Hospital of Alexandroupoli Alexandroupoli, Alexandroupolis, Greece
  • Sotiria Thoracic Diseases Hospital of Athens Athens, Attica, Greece
  • Aretaieio University Hospital of Athens Athens, Attica, Greece
  • University General Hospital of Athens Attikon Athens, Attica, Greece
View Trial Details
Completed

A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors

NCT04045496

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +55 more
Locations
  • HealthONE Clinic Services Oncology-Hematology Denver, Colorado, United States
  • Tennessee Oncology, PLLC Nashville, Tennessee, United States
  • The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
  • Washington University School of Medicine Seattle, Washington, United States
View Trial Details
Completed

A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A)

NCT05342636

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
Locations
  • Liga Norte Riograndense Contra o Câncer ( Site 2303) Natal, Rio Grande do Norte, Brazil
  • Hospital Nossa Senhora da Conceição ( Site 2301) Porto Alegre, Rio Grande do Sul, Brazil
  • ICESP - INSTITUTO DO CÂNCER DO ESTADO DE SÃO PAULO ( Site 2300) São Paulo, Brazil
  • FALP-UIDO ( Site 2400) Santiago, Region M. de Santiago, Chile
View all 46 locations
View Trial Details
Completed

Combination Study With Eftilagimod Alpha (a Soluble LAG-3 Fusion Protein) and Pembrolizumab in Patients With Recurrent or Metastatic HNSCC

NCT04811027

Conditions
Carcinoma, Carcinoma, Squamous Cell, HNSCC, +6 more
Locations
  • University of Alabama at Birmingham (UAB) - O'Neal Cancer Center Birmingham, Alabama, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Oncology Consultants Houston, Texas, United States
  • Macquarie University Hospital Macquarie Park, New South Wales, Australia
View all 28 locations
View Trial Details
Completed

Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)

NCT04428151

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • City of Hope ( Site 1519) Duarte, California, United States
  • UCLA Hematology/Oncology - Westwood (Building 100) ( Site 1568) Los Angeles, California, United States
  • Yale-New Haven Hospital-Yale Cancer Center ( Site 1505) New Haven, Connecticut, United States
  • Georgetown University Medical Center ( Site 1520) Washington D.C., District of Columbia, United States
View all 120 locations
View Trial Details
Completed

Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)

NCT03358472

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +7 more
Locations
  • Pacific Cancer Medical Center Anaheim, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • St. Joseph Heritage Healthcare Santa Rosa, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
View all 73 locations
View Trial Details

Related conditions